(Q37825558)

23 August 2017

1 reference

title

Acne-associated syndromes: models for better understanding of acne pathogenesis (English)

1 reference

23 August 2017

0 references

W Chen

1

1 reference

23 August 2017

B Obermayer-Pietsch

2

1 reference

23 August 2017

J-B Hong

3

1 reference

23 August 2017

B C Melnik

4

1 reference

23 August 2017

O Yamasaki

5

1 reference

23 August 2017

C Dessinioti

6

1 reference

23 August 2017

Q Ju

7

1 reference

23 August 2017

A I Liakou

8

1 reference

23 August 2017

S Al-Khuzaei

9

1 reference

23 August 2017

A Katsambas

10

1 reference

23 August 2017

J Ring

11

1 reference

23 August 2017

C C Zouboulis

12

1 reference

23 August 2017

publication date

29 December 2010

1 reference

Journal of the European Academy of Dermatology and Venereology

23 August 2017

published in

1 reference

23 August 2017

volume

25

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

637-646

1 reference

What is the pathogenesis of acne?

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Isolation of human sebaceous glands and cultivation of sebaceous gland-derived cells as an in vitro model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

The sebocyte culture: a model to study the pathophysiology of the sebaceous gland in sebostasis, seborrhoea and acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

21 January 2018

Models in acnegenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Propionibacterium acnes and sebaceous lipogenesis: a love-hate relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

An update to 21-hydroxylase deficient congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

An update of congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Extensive clinical experience: nonclassical 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Refractory acne and 21-hydroxylase deficiency in a selected group of female patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

What every physician should know about polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

The prevalence of non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Greek women with hirsutism and polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Androgen excess in women: experience with over 1000 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Congenital adrenal hyperplasia and acne in male patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Sexual hormones in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

21 January 2018

Mild androgen phenotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Dermatology of androgen-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Acne and sebaceous gland function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Hormones and the pilosebaceous unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

The role of facial sebum secretion in acne pathogenesis: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

New developments in our understanding of acne pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Acne vulgaris. The role of hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

The clinical evaluation of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

21 January 2018

Anti-androgen treatments

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Hormonal antiandrogens in acne treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Pituitary and testicular function in sons of women with polycystic ovary syndrome from infancy to adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Family-based analysis of candidate genes for polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

The role of genes in the polycystic ovary syndrome: predisposition and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Ovarian and adrenal function in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Insulin-sensitizing agents in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Androgen excess disorders in women: the severe insulin-resistant hyperandrogenic syndrome, HAIR-AN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Clinical profiles, occurrence, and management of adolescent patients with HAIR-AN syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Interplay of IGF-I and 17beta-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Biliopancreatic diversion as a novel approach to the HAIR-AN syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Clearance of acanthosis nigricans associated with the HAIR-AN syndrome after partial pancreatectomy: an 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Acute pseudoseptic arthritis and palmoplantar pustulosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

"SAPHO syndrome and infections".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

SAPHO syndrome: a long-term follow-up study of 120 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

SAPHO syndrome: MR appearance of vertebral involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Karyotypic analysis of bone marrow cells in pyodermic lesions associated with myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Pharmacological management of SAPHO syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

SAPHO syndrome treated with pamidronate: an open-label study of 10 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome treated with a combination of isotretinoin and pamidronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Autoinflammatory syndromes with a dermatological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Peculiarities of PAPA syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

The autoinflammatory syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Pilosebaceous abnormalities in Apert's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Role of FGFR2-signaling in the pathogenesis of acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Extracellular point mutations in FGFR2 elicit unexpected changes in intracellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

FoxO1 - the key for the pathogenesis and therapy of acne?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Is nuclear deficiency of FoxO1 due to increased growth factor/PI3K/Akt-signalling in acne vulgaris reversed by isotretinoin treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Epidermal mosaicism producing localised acne: somatic mutation in FGFR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Anti-acne agents attenuate FGFR2 signal transduction in acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Clinical and metabolic features of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03937.X

10.1111/J.1468-3083.2010.03937.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference